| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |